Dianthus Therapeutics ( DNTH ) announced pricing of its previously announced upsized underwritten public offering of 7.31M shares of common stock priced at $81.00 each. The total expected proceeds are around $625 million. Additionally, they are offering pre-funded warrants for 402,468 shares at $80.999 each, with a low exercise price. The offering was upsized from the initially proposed $400 milli...
Dianthus Therapeutics ( DNTH ) announced pricing of its previously announced upsized underwritten public offering of 7.31M shares of common stock priced at $81.00 each. The total expected proceeds are around $625 million. Additionally, they are offering pre-funded warrants for 402,468 shares at $80.999 each, with a low exercise price. The offering was upsized from the initially proposed $400 million to the final $625 million. The offering is set to close on March 12, 2026, pending standard closing conditions. The underwriters also have a 30-day option to buy an extra 1.16M shares. Dianthus plans to use the proceeds for advancing its clinical and preclinical development, preparing for commercial readiness, and for working capital and general corporate purposes. All securities are being offered by Dianthus. More on Dianthus Therapeutics Dianthus Therapeutics: Go Decision For CIDP Program Warrants Continued Buy Rating Dianthus Therapeutics, Inc. (DNTH) Discusses Interim Responder Analysis and Early Go Decision for CAPTIVATE Trial in CIDP Transcript Dianthus Therapeutics, Inc. (DNTH) Discusses Interim Responder Analysis and Early Go Decision for CAPTIVATE Trial in CIDP - Slideshow Dianthus Therapeutics announces proposed $400 million public share offering Seeking Alpha’s Quant Rating on Dianthus Therapeutics
German defense prime Rheinmetall AG posted a 2026 sales outlook of €14 billion to €14.5 billion ($16.3 billion to $16.9 billion), falling short of analyst expectations at a critical time for the company, as Europe’s military spending plans take shape. The company reported full-year sales of €9.9 billion, as political commitments slowly trickle down to manufacturers. “We are needed when it comes to...
German defense prime Rheinmetall AG posted a 2026 sales outlook of €14 billion to €14.5 billion ($16.3 billion to $16.9 billion), falling short of analyst expectations at a critical time for the company, as Europe’s military spending plans take shape. The company reported full-year sales of €9.9 billion, as political commitments slowly trickle down to manufacturers. “We are needed when it comes to increasing the defence capabilities of Germany and Europe and creating an effective deterrence. With our products, we will have a significant share in the increasing equipment spend of the armed forces and deliver what modern armed forces need in the 21st century,” Chief Executive Officer Armin Papperger said in an earnings statement on Wednesday. Rheinmetall reported an operating margin of 18.5% for the fiscal year, up from 15.2% the year before. The ammunition and armored vehicle maker’s order backlog now stands at record €63.8 billion, up €16.9 billion from a year earlier. In December, Rheinmetall adjusted its forecast in response to the planned sale of its civilian business early this year to one of two bidders. Numbers for the Power Systems segment are thus reported as discontinued operations in 2025. Rheinmetall’s shares are up 5.89% this year, as the stocks of European arms makers rally.
TAIPEI (Taiwan News) — Taiwan’s January manufacturing outlook improved to a green light as AI and high-performance computing demand surged, Taiwan Institute of Economic Research said Wednesday. TIER reported that the January manufacturing signal rose 1.32 points to 13.81, ending a 10-month streak in the low-growth yellow-blue or blue zones and reflecting a temporary boost from Lunar New Year timin...
TAIPEI (Taiwan News) — Taiwan’s January manufacturing outlook improved to a green light as AI and high-performance computing demand surged, Taiwan Institute of Economic Research said Wednesday. TIER reported that the January manufacturing signal rose 1.32 points to 13.81, ending a 10-month streak in the low-growth yellow-blue or blue zones and reflecting a temporary boost from Lunar New Year timing, per CNA . The gain was driven by strong demand for AI and high-performance computing, coupled with a low January baseline last year, the institute explained, per Liberty Times . Export orders and production indices rose sharply year-on-year, lifting raw material input indicators and manufacturing confidence. Sector performance showed improvement across the board. The share of blue-light sectors signaling slowdown fell from 46.6% in December to 19.72% in January, while green and yellow-red lights rose to 31.95% and 17.1%. Red lights fell to 11.58%, and combined blue and yellow-blue lights dropped to nearly 40%. TIER noted that variations in Lunar New Year timing can exaggerate monthly data, recommending that analysts observe trends over January and February combined. Ministry of Finance data indicate that AI-related industries remain strong, while traditional sectors are recovering. The electronics and optical products sector continued to boom, with servers, networking equipment, and semiconductor testing equipment posting export and production growth exceeding 100% year-on-year. Machinery also saw gains, driven by investment in advanced semiconductor processes and early stockpiling by manufacturers. Export orders and production indices rose steadily, pushing the sector from low-growth yellow-blue to neutral green. Despite momentum, TIER cautioned that US and Israeli military actions against Iran at the end of February have heightened geopolitical risks. Rising energy prices and potential supply chain disruptions could affect traditional industries and investment sentimen...
China’s most critical annual political gathering, the “two sessions”, is particularly significant this year as Beijing unveils its 15th five-year plan, signaling how it will position itself ahead of the highly anticipated summit between President Xi Jinping and his US counterpart Donald Trump. To decode the outcomes of these meetings, the South China Morning Post and the Asia Society Policy Instit...
China’s most critical annual political gathering, the “two sessions”, is particularly significant this year as Beijing unveils its 15th five-year plan, signaling how it will position itself ahead of the highly anticipated summit between President Xi Jinping and his US counterpart Donald Trump. To decode the outcomes of these meetings, the South China Morning Post and the Asia Society Policy Institute’s Center for China Analysis (CCA) will co-host a special webinar on March 13. The panel features Lizzi C. Lee, fellow on Chinese economy; Lyle Morris, senior fellow on foreign policy and national security; and Neil Thomas, fellow on Chinese politics, all from the Asia Society Policy Institute’s Center for China Analysis. They will be joined by moderator Neil Denslow, SCMP Plus senior production editor, to unpack the key outcomes of the meetings and evaluate their implications for China’s domestic trajectory, foreign policy direction and US-China relations. Advertisement The panel will explore the following topics: Economic policy: Premier Li Qiang’s government work report, economic targets, and policy priorities US-China relations: how the meetings set the stage for the expected summit between Xi and Trump Technological self-reliance: which sectors will be prioritised amid rising global uncertainty The 15th five-year plan: laying out China’s economic and social priorities for the next half-decade For in-depth coverage of the two sessions, subscribe to SCMP Plus – your go-to source to decoding China. Gain access to exclusive FactSheets, best-in-class data visualisations and our “Between the Lines” series, where specialist reporters annotate key government documents. You’ll also receive the Daily Pulse newsletter, delivering concise insights, expert context, and a curated briefing of global media perspectives.
Pakistan will come to the aid of Saudi Arabia whenever needed, according to the spokesman for Prime Minister Shehbaz Sharif , as Iran retaliates against US-Israeli strikes by hitting Gulf nations. Saudi Arabia and nuclear-armed Pakistan, which shares a border with Iran , signed a defence pact in September last year, elevating their long-standing security partnership, which is being tested by the M...
Pakistan will come to the aid of Saudi Arabia whenever needed, according to the spokesman for Prime Minister Shehbaz Sharif , as Iran retaliates against US-Israeli strikes by hitting Gulf nations. Saudi Arabia and nuclear-armed Pakistan, which shares a border with Iran , signed a defence pact in September last year, elevating their long-standing security partnership, which is being tested by the Middle East crisis. There was “no question we might, we will” come to Saudi Arabia’s aid “no matter what and no matter when”, Mosharraf Zaidi said on Wednesday. Advertisement “Both countries, even before the defence agreement, have always operated on the principle of being there for the other,” he said. A man cycles past an electronic board reading “Our Armed Forces are our pride and honour. A fortified sky and a protected land, by the will of God.” in the Saudi capital of Riyadh on Tuesday. Photo: AFP “The real question is what is Pakistan doing to make sure things don’t come to a point where any of its closest partners are further embroiled in a conflict that could potentially undermine stability and prosperity in the region.”
(RTTNews) - Galderma Group AG (GALD.SW, GDERF), a Swiss-based, pure-play dermatology company, on Thursday on Wednesday agreed to repurchase 1.6 million shares. The share repurchase is expected to settle on March 13 and will be financed using the company's existing liquidity. The shares are being repurchased for a total of about CHF 232 million in the context of an accelerated bookbuild offering of...
(RTTNews) - Galderma Group AG (GALD.SW, GDERF), a Swiss-based, pure-play dermatology company, on Thursday on Wednesday agreed to repurchase 1.6 million shares. The share repurchase is expected to settle on March 13 and will be financed using the company's existing liquidity. The shares are being repurchased for a total of about CHF 232 million in the context of an accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH, Abu Dhabi Investment Authority and Auba Investment Pte. Ltd. The company will buy the shares at CHF 143.75 apiece, the same price determined in the bookbuilding offering. Following the transaction, the selling shareholders have fully divested their remaining stake in the company. Following the closing of the accelerated bookbuild offering, the free float of Galderma's shares is expected to increase to about 80% from 65%. Galderma Group AG closed trading 0.83% lesser at CHF 154.60 on the Swiss Stock Exchange. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
primeimages Cliffwater LLC’s flagship $33B Cliffwater Corporate Lending Fund is facing investor redemption requests exceeding 7% of assets, Bloomberg reported, citing sources familiar with the matter. The Cliffwater Corporate Lending Fund focuses on senior-secured private direct loans, manages about $33B in assets, and is structured as an interval fund, requiring it to repurchase up to 5% of its s...
primeimages Cliffwater LLC’s flagship $33B Cliffwater Corporate Lending Fund is facing investor redemption requests exceeding 7% of assets, Bloomberg reported, citing sources familiar with the matter. The Cliffwater Corporate Lending Fund focuses on senior-secured private direct loans, manages about $33B in assets, and is structured as an interval fund, requiring it to repurchase up to 5% of its shares each quarter if investor requests meet that threshold. If requests exceed 5%, the manager can increase the buyback to as much as 7% at its discretion. Cliffwater has not yet decided whether it will cap withdrawals at 5% or 7%, according to the report . The fund’s tender window is set to close Tuesday The redemption pressure reflects broader stress in the private credit market tied to credit quality concerns, which has led to increased investor anxiety and a rise in withdrawal requests from funds like Cliffwater. More on Cliffwater Dividend scorecard for Cliffwater Corporate Lending Fund I Dividend scorecard for Cliffwater Enhanced Lending Fund I Compare metrics for CCLFX to CELFX, CCLDX